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Fibrotic disorders involve replacement of normal parenchyma with myofibroblasts, which
deposit connective tissue, leading to obliteration of the function of the underlying
organ. The treatment options are inadequate and reflect the fact that signaling targets
in myofibroblasts are unknown. Here we identify the hyperactive Lyn signaling in
myofibroblasts of patients with chronic pancreatitis-induced fibrosis. Lyn activation
coexpress with markers of activated myofibroblasts, and is increased∼11-fold in chronic
pancreatitis compared to normal tissue. Inhibition of Lyn with siRNA or INNO-406 leads
to the substantial decrease of migration and proliferation of human chronic pancreatitis
myofibroblasts in vitro, while leaving migration and proliferation of normal myofibroblasts
only slightly affected. Furthermore, inhibition of Lyn prevents synthesis of procollagen and
collagen in myofibroblasts in a mouse model of chronic pancreatitis-induced fibrosis.
We conclude that Lyn, as a positive regulator of myofibroblast migration, proliferation,
and collagen production, is a key target for preventing fibrosis.
Keywords: fibrosis, Lyn, Src, pancreatitis
INTRODUCTION
Fibrosis can occur in many tissues within the body as a result of inflammation or damage.
Chronic pancreatitis is an inflammation of the pancreas that leads to fibrotic replacement of the
parenchyma, and severe complications, including loss of exocrine and endocrine function, which
often leads to secondary diabetes mellitus type 3c (T3cDM) and cancer (Omary et al., 2007).
Although it is proven that activated, α-smooth muscle actin (α-SMA)-positive, collagen-producing
myofibroblasts (stellate cells), play a key role in infiltration, and replacement of pancreatic
parenchyma, no fully effective anti-fibrotic therapies exist to date due to the limited understanding
of the key driving signaling mechanisms in these cells (Apte et al., 1998; Omary et al., 2007;
Vonlaufen et al., 2010). Parenchyma is also replaced with myofibroblasts and connective tissue
during chronic inflammation of liver, and other organs, for which the therapeutic targets are largely
unknown, as well. New treatment targets and paradigms are therefore needed.
Abbreviations: α-SMA, alpha smooth muscle actin; CXCR4, chemokine (C-X-C motif) receptor 4; F4/80, a mature mouse
cell surface glycoprotein expressed at high levels on various macrophages; INNO-406, Bafetinib, a potent and selective Lyn
inhibitor; Lyn, LYN proto-oncogene, Src family protein tyrosine kinase; PAI-1, plasminogen activator inhibitor-1; PP2 (kinase
inhibitor), 4-amino-5-(4-chlorophenyl)-7-(dimethylethyl)pyrazolo[3,4-d]pyrimidine; SDF-1, stromal-cell derived factor-1,
chemokine; siRNA, small interfering RNA, a synthetic RNA duplex designed to specifically target a particular mRNA for
degradation; Syk, spleen tyrosine kinase, non-receptor type Tyr protein kinase; Src, SRC proto-oncogene, non-receptor
tyrosine kinase.
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SDF-1 (stromal cell-derived factor 1) chemokine and its
receptor, CXCR4 (Nagasawa et al., 1996), are known as the key
regulators of migration of stem/progenitor cells, leukocytes, and
other cells, within their local tissue microenvironment. We, and
others, have previously shown that Lyn kinase is involved in
chemoattractant signaling (Ptasznik et al., 1995, 1996; Mócsai
et al., 2000) and is required for CXCR4-mediated chemotaxis of
hematopoietic cells andmacrophages (Ptasznik et al., 2002; Malik
et al., 2008; Tabe et al., 2012). Here we provide results indicating
that Lyn is also required for CXCR4-mediated migration of
stellate cells in inflamed pancreas.
Lyn has not been linked to fibrotic process in pancreas to
date. However, two prior studies have linked Lyn kinase activity
to other fibrotic processes. Lyn inhibition attenuates fibrosis
in chronic allograft nephropathy models through prevention
of plasminogen activator inhibitor-1 (PAI-1), a powerful pro-
fibrotic mediator (Pontrelli et al., 2006). Another group suggested
that Lyn nitration increases Syk activity and regulates hepatic
stellate cell apoptosis in the course of chronic fibrosis of liver
(Mòdol et al., 2011). Thus, the mechanisms and consequences are
complex and variable. Here we provide evidence that Lyn activity
is selectively increased in stellate cells during chronic pancreatitis,
which leads to their hyperactive CXCR4-mediated migration,
increased proliferation, and excessive collagen production,
resulting in chronic fibrosis of pancreas. We suggest that by
targeting Lyn, an effective therapy for previously untreatable
pancreatic fibrosis may ensue.
MATERIALS AND METHODS
Human Pancreatic Stellate Cells
Human stellate cells were examined using freshly harvested
pancreatic tissue or freshly isolated primary human stellate cells
in culture. Surgical pancreatic samples were obtained from 10
chronic pancreatitis patients, or donors without any pancreatic
disease, using guidelines approved by the Institutional Review
Board of the Cedars-Sinai Medical Center, Los Angeles, and
University of Washington, Seattle. According to the de-identified
Surgical Pathology Reports all patients had chronic pancreatitis
and fibrotic pancreas, mostly due to intraductal obstructions.
Stellate cells were isolated from human pancreatic tissue (by
using the tissue digestion method with pronase, collagenase, and
DNAse), identified, and expanded in culture, using the same
methods as described in detail for rat pancreatic tissue (Apte
et al., 1998). In our experiments, we used the early passage
cells to minimize any potential effect of prolonged culturing on
primary cells. The passage number of chronic pancreatitis or
normal cells was always identical for chronic pancreatitis and
normal cells during each set of experiment. At 24 h in culture
at least 95% of cells had attached to the wells and had assumed
a stellate, angular appearance with prominent lipid droplets in
the cytoplasm. According to this particular method, purity of the
preparation is ultimately ∼100% (after a few passages in tissue
culture) as assessed by vitamin A autofluorescence in quiescent
stellate cells and α–SMA, and procollagen expression in activated
stellate cells (myofibroblasts), as earlier described (Apte et al.,
1998; Vonlaufen et al., 2010).
In vivo Effects of INNO-406 on Chronic
Pancreatitis-Induced Fibrosis in Mouse
Model
A most commonly used experimental model of chronic
pancreatitis-induced fibrosis partially recapitulating human
disease is repeated injection of cerulein into mice (Ulmasov et al.,
2013). C57BL/6 is the most frequently used mouse strain for this
type of biomedical research (Ulmasov et al., 2013). Fibrosis may
be reversible only in its early stages. A large body of evidence
indicates that established fibrosis results from the replacement
of parenchyma with fibrotic tissue and is associated with the
massive loss of parenchyma due to necrosis and apoptosis, which
in result is irreversible. Therefore, in our current experiments we
were focused on preventing fibrosis. Accordingly, C57BL/6J mice
(2 months old male and female) were divided into 3 groups (each
group consisted of 15 animals) as follows: (1) untreated mice
(saline only); (2) mice treated with cerulein for 6 weeks (50µg/kg
hourly, 6 hourly injections in one day constituted one treatment,
twice-weekly); (3) mice treated with cerulein (as above) plus
120mg INNO-406/kg per day for 6 weeks (oral gavage). When
120mg INNO-406/kg per day is administrated orally to the
mice, the concentration of INNO-406 in the soft tissues is
estimated to be 0.24 µM according to detailed pharmacokinetic
studies described previously (Kimura et al., 2005; Yokota et al.,
2007). To allow resolution of acute inflammatory changes (in
order to make fibrosis clearly visible and detectable), all mice
were euthanized at 5 days after their final cerulein and INNO-
406 treatment. Histopathologic pancreas comparison (based on
staining with Hematoxylin plus Eosin) confirmed predominantly
fibrosis (score 2) with only mild inflammatory infiltrate (score
1) in cerulean-treated mice, in contrast to untreated or cerulean
plus INNO-406-treated mice (scores 0). Fibrosis was scored from
0 to 3 (none to extensive fibrosis) and inflammatory infiltrate was
scored from 0 to 3 (none to profuse infiltration), as described in
detail (Nathan et al., 2010).
In vivo Effects of INNO-406 on Acute
Pancreatitis in Mouse Model
In order to determine whether INNO-406 could potentially
prevent the recurrent acute pancreatitis leading to chronic
pancreatitis and fibrosis in humans, we investigated the ability
of 3 days of pretreatment with INNO-406 to prevent cerulean-
induced acute pancreatitis in mice. The primary objective was
to test the hypothesis that the proportion of animals with acute
pancreatitis following cerulein challenge is significantly lower
in animals pre-treated with INNO-406 than in animals pre-
treated with placebo. The study was conducted as a randomized,
investigator-blinded, controlled, parallel group assessment of the
efficacy of INNO-406 in mice with cerulein-induced pancreatitis.
Mice C57BL/6, sex: male and female, age: 5–6 weeks, weight:
∼20–25 g. The study involved dosing 20 mice with INNO-
406 (120 mg/kg body weight) or 20 mice with matching
placebo (0.5% Carbomethycellulose plus DMSO) by gavage
for 3 consecutive days. On the 3rd day, 2 h after gavage,
animals received 7 consecutive doses of cerulein (IP, 50 µg/kg
body weight) administered at 1-h intervals. At the end of the
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treatment, on the 3rd day, mice were euthanized and laparotomy
was performed and pancreas and blood was collected from
euthanized animals for biochemical and histological analysis.
Primary efficacy measure: proportion of animals with histologic
evidence of pancreatitis. Sections of pancreas were stained
with hematoxylin and eosin. Reader evaluated 20 high-powered
fields and recorded the score for the field with the most
severe pathology. Secondary efficacy measure: mean pancreas
weight/body weight, mean serum amylase, mean serum lipase,
mean tissue trypsin, markers of inflammation in pancreas (IL-6,
TNF-alpha). The proportions of animals with histologic evidence
of pancreatitis in the two treatment groups were compared using
Fisher’s Exact Test. Other measures were compared using an
unpaired t-test with Welch correction.
Immunohistochemistry
The relationship between pancreatic stellate cell activation and
pancreatic fibrosis was studied in mice by dual staining of
sections for α-SMA plus Picro-Sirius Red for collagen protein
(Figure 3A). Briefly, frozen tissue sections were fixed with
acetone for 10 min at room temperature, stored at −20◦C
before use and then air-dried for 20 min at room temperature.
Sections were washed with PBS three times for 5 min each.
Sections were incubated with 0.3% H2O2 for 10 min to block
endogenous peroxidase activity and then washed. To prevent
nonspecific binding of antibody, sections were incubated for in
a humidified chamber at room temperature for 30 min with
a rodent blocking solution (Rodent Block M, Biocare Medical,
catalog no. RBM961). Sections were washed again three times
for 5 min each and then incubated overnight at 4◦C with the
anti-alpha SMA primary antibody (mouse monoclonal antibody,
clone 1 A4; Sigma-Aldrich, catalog no. A2547), diluted 1:700 in
PBS. After further washes, the secondary antibody (Envision+
System-HRP Anti-mouse, Dako, catalog no. K4001) was applied
for 1 h at room temperature. After further washes, the color
was developed using 3.3-diaminobenzidine tetrahydrochloride
(DAB) Peroxidase (HRP) Substrate Kit (Vector Laboratories,
catalog no. SK4100). Sections were successively washed with PBS
three times for 5 min each. Next, slides were incubated for 20
min with Picro Sirius red solution (Abcam, catalog no. 150681)
followed by a brief rinse with acetic acid (0.05%). Sections
were dehydrated by washing with absolute alcohol, cleared by
washing in Xylene, and covered with synthetic resin (StatLab,
Acrymount, catalog no. SL80-4). Morphometric and statistical
analysis. For the quantification of fibrosis, tissue sections derived
from mice of each group (untreated, cerulein-treated, cerulein+
INNO-406-treated) were stained with Picro Sirius red solution
alone, according to the manufacturing instructions. The slides
were digitally scanned at 20X on an Aperio ScanScopAT Turbo
(Leica, Buffalo Grove, IL) and stored on Cedars-Sinai server
by the Cedars-Sinai Confocal Microscopy Core Facility. Picro
Sirius red quantitation was performed using Leica Biosystem
Tissue IA Optimizer. For each slide, 15 areas were selected by
an investigator, who was unaware of the sample identity, and
averaged as a percentage (positive stained area [µm2] per total
area examined [µm2]). Statistical significance of differences in
data values was validated by analysis of variance (ANOVA),
followed by Sidak’s Multiple Comparison Test using the Prism-
6 statistical package (Graph Pad Software, San Diego, CA), with
significance limit set at p < 0.05.
Immunofluorescence
Immunocolocalizations of CXCR4 and α–SMA in pancreatic
tissue specimens derived from patients with chronic pancreatitis
and normal donors (Figure 1F), or procollagen and α–SMA
and F4/80 in pancreatic specimens derived from cerulein-
treated or cerulein + INNO-406-treated and untreated control
mice (Figure 3B), were performed following a method of
indirect immunofluorescence with minor modifications, as
described (Cirulli et al., 2000; Yebra et al., 2003; Diaferia
et al., 2013). Briefly, two and three color immunofluorescence
was performed on paraffin sections using standard procedures
of deparaffinization followed by antigen retrieval, blocking of
aldehyde residues with glycine, and incubation overnight with
primary antibodies. Primary antibodies used were: rabbit anti-
CXCR4 (Cat#ab2074, Abcam, Cambridge, MA), mouse anti-
CXCR4 (Cat# ab58176, Abcam, Cambridge, MA), mouse anti-
αSMA (Cat# A2547, Sigma, St. Louis, MO), goat anti-
Procollagen-A17 (SC25973, Santa Cruz Biotechnology, Inc., CA),
rat anti-F4/80 (Cat# ab6640, Abcam, Cambridge, MA), and
mouse anti-E-cadherin (Becton Dickinson, Clone 36/ecad). After
primary antibody reaction, sections were challengedwith species-
specific fluorophore-labeled F(ab)2 secondary antibodies LRSC-
donkey anti-rabbit and FITC-donkey anti-mouse, anti-goat, or
anti-rat, and LRSC-donkey anti-goat (Jackson ImmunoResearch,
West Grove, PA). After staining, sections were mounted with
DAPI mounting medium to visualize nuclei, and analyzed at
a NIKON Eclipse 90i microscope, equipped with a CoolSNAP-
HQ2 CCD camera (Photometrics). Morphometric and statistical
analysis. Extensive morphometric analysis of human tissues was
performed on at least 30 sections per tissue samples, collected
from three cases of pancreatitis and three normal pancreata,
using the NIS Elements 3.22 software (Nikon). Collectively,
morphometric analysis of human specimens was performed
on 150 images per human tissue group (i.e., pancreatitis or
normal pancreas) collected from a total of 180 tissue sections.
Morphometric cell counts in mouse tissues were performed on
a total of 120 sections (from control mice, and from mice treated
with either Cerulein alone, or Cerulein + INNO-406). At least
150 images were acquired per animal group. Stained sections
were then viewed on a Nikon Eclipse 90i, and morphometric
measurement performed using Nikon Pro Plus software (Media
Cybernetics, Inc.). Statistical significance of differences in data
values was validated by analysis of variance (ANOVA), followed
by Bonferroni’s Multiple Comparison Test, or by two tailed
student’s t-test, using the Prism-4 statistical package (Graph Pad
Software, San Diego, CA), with significance limit set at p < 0.05.
Immune Complex Kinase Assay
Preliminary qPCR experiments determined that only two
members of the Src family, Src and Lyn, were substantially
expressed in normal and chronic pancreatitis human pancreatic
stellate cells. Thus, we performed in vitro kinase assays on
Src or Lyn immunoprecipitates (Ptasznik et al., 1995, 1996) to
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FIGURE 1 | Increased Lyn kinase activity and CXCR4 receptor expression in activated α-SMA-positive stellate cells in human chronic pancreatitis.
Pancreatic stellate cells were isolated from chronic pancreatitis patients (hCP) and normal donors (hNP). Subsequently, we performed Lyn and Src kinase assays
(A,B), and western blottings for Lyn, Src, α-SMA (C) and total CXCR4 protein (D) in these cells. Kinase assays and Western blot analysis were normalized to the
housekeeping gene GAPDH. (E) Flow cytometry analysis ofCXCR4 receptor expression on stellate cells of chronic pancreatitis (black) and normal subject (blue). Cells
were stained with or without (red) anti-human CXCR4 antibody followed by secondary antibodies and analysis. (A–E) are shown for the same pancreatitis and normal
subject. We obtained the consistent results with the four different subjects (n = 4). (F) Representative fields are shown for chronic pancreatitis (n = 3) and normal
pancreas (n = 3). All images shown in this figure are representative of morphometric analysis performed on all human tissue. Bar graph represents the morphometric
and statistical analysis performed on 150 images per tissue group and indicates increased coexpression (yellow) of CXCR4 with α-SMA, and infiltration of
CXCR4+/α-SMA+ cells into atrophic parenchyma in pancreatitis tissue (arrows, top left quadrant), which is in contrast to the intact parenchymal structures in normal
pancreata (top right quadrant). This is consistent with western blot showing increased coexpression of α-SMA with CXCR4 in the pancreatitis patient (hCP) (C–E). For
further detail on morphometric and statistical analysis see Section Materials and Methods.
measure autophosphorylation (phosphorylation of the kinase
by itself sustains its activated state and leads to an increase
in enzymatic activity). Immunoprecipitation. Aliquots of stellate
cells from CP or normal subjects were normalized for cell
counts (3.5 × 106 assay), washed in 1×PBS, and lysed in
ice-cold lysis buffer (2% NP-40, 10 mM Tris, 50 mM NaCl,
30 mM sodium pyrophosphate, 50 mM NaF) supplemented
with protease inhibitor mixture as described (Ptasznik et al.,
1995, 1996). Protein concentrations on whole cell lysates were
determined by BCA protein assay. For immunoprecipitation, cell
lysates were incubated at 4◦C with 5 µl of Lyn or Src Ab for 4
h followed by 30 µl of Pansorbin beads for 2 h. Immunoblot
analysis of Lyn, Src, α–SMA, CXCR4, and GAPDH expression,
was conducted on immunoprecipitates generated as described
above, or directly on cell lysates containing 30 µg of protein.
Kinase assay. Lyn or Src immunoprecipitates were washed twice
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with lysis buffer (see above), and once with a buffer containing
10 mM Tris (pH 7.1), 100 mM NaCl, and 0.1 µM sodium
orthovanadate. Kinase assays were performed by resuspending
Lyn or Src immunoprecipitates in 30 µl kinase reaction mixture
(25 mM HEPES [pH 7.1], 10 mM MnCl2, 10 µCi [32P-γ]–ATP,
1 µM unlabeled ATP). Kinase reaction was carried out for 2 min
at 20◦C, and then the reaction was stopped by the addition of 30
µl sodium dodecyl sulfate (SDS) gel-loading buffer and boiling,
resolved by 8% SDS-PAGE, and visualized by autoradiography.
siRNA
Four short interfering siRNAs targeting human Lyn and
four non-targeting siRNAs (control) combined into one pool
(Thermo Scientific, catalog# L-003153-00-0010 and D-001210-
01-20, respectively) were prepared and stored frozen in aliquots
at −20◦C, as described in Supplementary Methods in our
previous paper (Ptasznik et al., 2004). A mixture of 4 Lyn
siRNAs provided as a single reagent (SMART pool) provides
advantages in both potency (reduces Lyn protein by 80–
95%) and specificity (very low “off target” silencing effects,
as demonstrated by the relevant functional rescue and PKR
kinase experiments; Ptasznik et al., 2004). Preparation of
primary fibroblast-like stellate cells before electroporation, as
well as electroporation with siRNAs, was performed according
to the manufacturer’s recommendations (for detailed protocols
please see the Amaxa 4D-Nucleofector Basic Protocol for
Primary Mammalian Fibroblasts and Amaxa 4D-Nucleofector
Optimization Protocol for Primary Cells, online).
Transwell Migration Assay with SDF-1 in
siRNA, AMD3100, and INNO-406-Treated
Cells
SDF-1 was obtained from PeproTech Inc. and AMD3100 from
Sigma-Aldrich (St. Louis, MO). INNO-406 was synthetized and
purified at Cellagen Technology (San Diego, CA). The migration
assays were performed by using Transwell migration assays with
polycarbonate membrane inserts with 8 µm pore size that is
optimal for fibroblast-like cell migration (Corning Incorporated,
NY, cat # 3422). Stellate cells were treated with siRNA (100
nM) for 48 h, or with increasing concentrations of AMD3100
(5–50 µM) or INNO-406 (10–100 nM) for 60 min. Then, cells
were placed in the migration upper chambers, in the presence or
absence of SDF-1 (0.025µM)with 2% FBS in the lower chambers.
After 2 h of incubation, cells migrated to the lower chamber were
counted, and the chemotactic index was determined as follows:
(number of cells migrating to SDF-1 chemokine)/(number of
cells migrating to medium alone).
Viability/Proliferation Measurements
To be certain that unintended cytotoxic effects were not
responsible for the observed decreases in cell migration, in
siRNA or AMD3100 or INNO-406-treated cells, control viability
measurements were carried out by trypan blue exclusion
assay (not shown) and MTT assay, during the course of
these experiments. As the positive controls for our viability
measurements we used stellate cells deprived serum for 24–
48 h (not shown). We consistently observed that stellate cells
isolated from patients with chronic pancreatitis (hCP) had higher
proliferation/viability rate than cells isolated from normal donors
(hNP), and Lyn-dependent viability was increased in hCP as
compared to hNP. The stellate cell accumulation problem in
chronic pancreatitis is a balance equation where: rate of stellate
cell accumulation = rate of stellate cell proliferation – rate of
stellate cell death. Therefore, we believe that MTT viability assay
is the most proper to use in this particular case.
RESULTS
Lyn is Excessively Active in Stellate Cells
of Patients with Chronic Pancreatitis
We began by screening for the activities of known Src family
kinases in stellate cells isolated from pancreata of donors with
or without chronic pancreatitis (Figure 1). After isolation of
stellate cells from human pancreatic tissues, kinase assays showed
activities in Lyn and Src immunoprecipitates (Section Materials
and Methods). We detected a ∼11-fold increase in Lyn kinase
activity in cells isolated from chronic pancreatitis compared to
cells from normal subjects (Figure 1A). Importantly, we found
no increase in Src activity (a kinase of similar structure and
function to Lyn; Figure 1B). Thus, increase of Lyn activity in
stellate cells of chronic pancreatitis was selective. There was no
change in the levels of Lyn or Src proteins, as determined by
western blotting (Figure 1C). Importantly, α–SMA, a marker of
activation of stellate cells as we described (Omary et al., 2007) was
increased in stellate cells from subjects with chronic pancreatitis
compared to those from normal subjects (Figure 1C). These data
indicated that increased Lyn kinase activity was associated with
activation of stellate cells in chronic pancreatitis patients.
CXCR4(+) Stellate Cells Infiltrate the
Pancreatic Parenchyma of Patients with
Chronic Pancreatitis
Next, we investigated the expression of CXCR4 in stellate
cells isolated from chronic pancreatitis patients and normal
subjects in cultured primary human stellate cells, and also
in human pancreatic sections. Western blot analysis of total
proteins, normalized to the housekeeping gene GAPDH,
showed no differences in the total (surface + intracellular)
cellular expression of CXCR4 in stellate cells isolated from
chronic pancreatitis patients and normal donors (Figure 1D).
In contrast, as indicated by flow cytometry analysis, the mean
percentages of stellate cells expressing surface CXCR4 were
significantly increased in chronic pancreatitis, as compared
to normal cells (Figure 1E). These data indicate that CXCR4
receptor internalization and recycling are altered in chronic
pancreatitis stellate cells, as compared to normal stellate cells.
Immunocolocalization studies (Section Materials and Methods)
indicated the significant colocalization of CXCR4 with α–SMA
(marker of activated stellate cells), reaching a ∼15-fold increase
in chronic pancreatitis tissues, as compared to normal pancreata
(Figure 1F). Notably, normal pancreatic tissues exhibited sparse
CXCR4-positive activated stellate cells localized between the
intact lobular parenchymal structures (top right quadrant in
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FIGURE 2 | The robust differential chemotactic response to stimulation or inhibition of CXCR4/Lyn signaling between activated stellate cells of
chronic pancreatitis (hCP) and normal donors (hNP). (A) Control Western blottings were performed 48 h after electroporation with siRNA. (B) Cells were
stimulated with control buffer or 0.025 µM SDF-1 for 2 h, n = 4. (C–E) Cells were treated with AMD3100, siRNA, or INN0-406, as indicated, and subsequently we
performed chemotaxis assays in SDF-1 stimulated or unstimulated cells (n = 4). (F) Control cell counts in growing chronic pancreatitis (hCP) vs. normal (hNP) stellate
cells, and control MTT viability assays were performed 24 and 72 h after electroporation with siRNA (n = 6).
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Figure 1F). In sharp contrast, chronic pancreatitis exhibited
dense CXCR4-positive activated stellate cells infiltrating atrophic
pancreatic parenchyma (see top left quadrant Figure 1F). These
results indicated that the number of CXCR4-positive stellate
cells, infiltrating the pancreatic parenchyma, was dramatically
increased in chronic pancreatitis compared to normal pancreas.
All images that are showed in Figure 1F are representative of an
extensive morphometric analysis performed on all human tissue
(see the bar graph in Figure 1F).
Differential Chemotactic Response to
Stimulation or Inhibition of CXCR4/Lyn
Signaling Axis in Stellate Cells of Chronic
Pancreatitis, as Compared to Normal
Donors
The differential kinase activity of Lyn in pancreatitis stellate
cells vs. normal stellate cells (Figure 1A) supports choosing
Lyn as a therapeutic target. We silenced Lyn expression in
chronic pancreatitis patient-and normal donor-derived stellate
cells, using siRNA (Ptasznik et al., 2004). After treatment of the
cells (Section Materials and Methods), Western blotting showed
a ∼80–95% reduction in Lyn protein (Figure 2A). Importantly,
we found no inhibitory effect on Src, another Src family kinase
of similar structure and size (Figure 2A). Thus, the inhibition
of Lyn by siRNA was robust and selective. We also employed a
mechanistically distinct approach to inhibit Lyn in stellate cells
by using Lyn kinase inhibitor INNO-406 (Bafetinib). INNO-406
was previously shown to be an effective Lyn inhibitor at clinically
relevant concentrations without affecting the phosphorylation of
Src and several other Src family members (Kimura et al., 2005;
Yokota et al., 2007). Thus, INNO-406 is a selective inhibitor of
Lyn and not a broad Src family kinase inhibitor.
We then investigated the SDF-1/CXCR4-induced chemotactic
response of chronic pancreatitis and normal stellate cells.
Chronic pancreatitis cells showed increased CXCR4-induced
chemotaxis by ∼three-fold as compared to normal cells
(Figure 2B), which could be blocked by treatment with
AMD3100, a specific antagonist for the SDF-1 receptor CXCR4
(Figure 2C). The selective ablation of Lyn by siRNA (Figure 2A)
effectively inhibited chemotaxis of pancreatitis stellate cells
(Figure 2D). We also observed strong inhibition of chemotaxis
following treatment with INNO-406 (Figure 2E). Notably,
inhibition of chemotaxis by Lyn inhibitors (siRNA or INNO-
406) was much stronger in stellate chronic pancreatitis cells than
in normal cells (Figures 2D,E), consistent with differential Lyn
kinase activity (Figure 1A). In addition, the selective ablation
of Lyn by siRNA (Figure 2A) effectively inhibited viability of
chronic pancreatitis stellate cells at 72 h, while leaving viability
of normal stellate cells not affected (Figure 2F). These findings
indicated that Lyn stimulated both chemotaxis and viability of
stellate cells (this function of Lyn was previously established in
other cellular systems; O’Laughlin-Brunner et al., 2001; Ptasznik
et al., 2002) and Lyn-mediated chemotaxis and viability of stellate
cells were increased in chronic pancreatitis, consistent with
hyperactive Lyn kinase in chronic pancreatitis (Figure 1A).
Lyn is a Key Target for Preventing Chronic
Pancreatitis-Induced Fibrosis
Our findings with human primary stellate cells support targeting
Lyn in chronic pancreatitis patients by showing that Lyn
activity is differentially expressed in stellate cells of chronic
pancreatitis compared to normal subjects, and inhibition of Lyn
leads to the significant chemotaxis and proliferation decrease
of primary chronic pancreatitis stellate cells in vitro, while
leaving chemotaxis and proliferation of normal stellate cells
only slightly affected (Figures 1, 2). Although it is known that
selective inhibition of one of the many chemokine receptors can
be easily bypassed in vivo through other chemokine receptors in
chronic inflammation, including chronic pancreatitis, targeting
a common downstream intracellular target may inhibit the
bypass effect. This is important because the mean percentages
of stellate cells expressing surface CCR5 (in addition to CXCR4)
were significantly increased in chronic pancreatitis as compared
to normal stellate cells (not shown), and CCR5 mediates Lyn
signaling in other cellular systems. Inhibition of Lyn would
therefore be difficult to bypass in vivo, because Lyn is a
common downstream target of several key pro-inflammatory
chemoattractant receptors, including CXCR4, CCR5, and fMLP
receptor (Ptasznik et al., 1995, 1996, 2002; Mócsai et al., 2000;
Nakata et al., 2006; Tomkowicz et al., 2006; Malik et al., 2008;
Tabe et al., 2012; Hu et al., 2014). Thus, inhibition of Lyn prevents
the chemotactic and proliferative action of several receptors in
different cellular systems (Ptasznik et al., 1995, 1996, 2002; Malik
et al., 2008; Tabe et al., 2012).
We therefore performed in vivo validation of Lyn as a single
therapeutic target in myofibroblasts of chronic pancreatitis-
induced fibrosis (Section Materials and Methods). The all images
that are showed in our paper are representative of an extensive
morphometric analysis performed on the mice pancreatic tissue
(see the bar graphs in Figure 3). Dual staining approaches
revealed fibrosis and a strong association between fibrosis and
activated stellate cells in pancreas of cerulein-treated mice
(Figure 3A). In the cerulein-treated mice, Sirius Red collagen
staining was intense and collagen was adjacent to α–SMA-
positive myofibroblastic stellate cells (Figure 3A). The extent of
fibrosis was substantially reduced in mice treated for 6 weeks
with both cerulein and Lyn kinase inhibitor INNO-406 and there
was less collagen adjacent to α–SMA-positive stellate cells in
these mice (Figure 3A). Immunocolocalization studies detected
numerous activated stellate cells coexpressing procollagen and
α–SMA in pancreata from cerulean-treated mice, as compared
to untreated mice, reaching a ∼30-fold increase (Figure 3B).
Treatment of mice with INNO-406, in conjunction with
cerulein, resulted in a drastic reduction of procollagen-specific
immunoreactivity in α–SMA-positive stellate cells (Figure 3B).
In contrast, F4/80-positive macrophages identified in all groups
of mice did not exhibit procollagen-specific immunoreactivity,
as expected, and were not adjacent to activated stellate cells
expressing procollagen (Figure 3B). These results strongly
indicate that activated stellate cells co-localize with areas of
chronic pancreatic-induced fibrosis and are the source of Lyn-
mediated procollagen/collagen production.
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FIGURE 3 | Continued
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FIGURE 3 | Pancreatic fibrosis is prevented by treatment with Lyn kinase inhibitor, INN0-406, in a cerulein-induced mouse model of chronic
pancreatitis. (A) Dual staining (Picro-Sirius Red plus a-SMA) denotes fibrosis: collagen (dark red) with adjacent a-SMA positive activated myofibroblasts (green). (B)
Immunofluorescence, increased frequency of procollagen, and a-SMA-positive cells in mice with chronic pancreatitis. Procollagen and α-SMA coexpression in
myofibroblasts is highlighted by the appearance of a yellow color (arrows) resulting from the overlap of red and green. The frequency of cells coexpressing procollagen
and a-SMA is substantially decreased in INN0-406-treated mice. Note that the F4/80-positive macrophages (green, middle panel) do not exhibit procollagen-specific
immunoreactivity, and are not adjacent to myofibroblasts expressing procollagen (red). All images shown in this figure are representative of an extensive morphometric
analysis performed on the all mice pancreatic tissue (see the bar graphs). For detail on morphometric and statistical analysis see Section Materials and Methods.
DISCUSSION
We show that the ultimate results of Lyn inhibition in vivo is
reduced fibrosis (Figure 3), but the mechanism is still unclear.
The most likely mechanism for the inhibition of fibrosis in
vivo we have just described is suggested by observations that
INNO-406 and Lyn siRNA directly prevent chemokine-induced
cell movement, proliferation, and viability in purified activated
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stellate cells in vitro (Figure 2). We propose that the high
Lyn kinase activity in activated stellate cells (Figure 1A)
drives invasiveness and proliferation of these cells in chronic
pancreatitis. Therefore, the direct and selective inhibition of Lyn
kinase (using INNO-406 or siRNA) could prevent expansion
and infiltration of these fibroblastic cells and thus fibrosis.
Alternatively, it is possible that, in vivo, Lyn inhibition results in
reduced fibrosis by attenuating inflammatory tissue damage (e.g.,
by inhibition of inflammatory infiltration). Therefore, we also
examined whether INNO-406 could prevent acute pancreatitis in
a cerulein-induced pancreatitis mouse model (Section Materials
and Methods). We determined that there was no effect of
INNO-406 on the acute pancreatitis and inflammatory tissue
injury (not shown), ruling out inhibition of inflammation as
a major cause of reduced fibrosis in INNO-406-treated mice
(Section Materials and Methods). These findings suggest that the
selective Lyn inhibition results in reduced fibrosis by attenuating
movement, infiltration, proliferation, viability (Figure 2), and
collagen production (Figure 3) in stellate cells rather than by
direct attenuating pancreatitis and inflammatory tissue damage.
On first examination our present results seem to be in contrast
to our previous data indicating critical role of Src kinases,
including Lyn, in acute inflammation in general (Ptasznik et al.,
1995, 1996; Liu et al., 2013). However, since Lyn is also directly
associated with invasive cell phenotype, including aberrant
cell movement, infiltration and prolonged viability (Ptasznik
et al., 2002, 2004; Nakata et al., 2006; Malik et al., 2008),
it is possible that the hyperactive Lyn (Figure 1A) is simply
driving invasiveness of activated myofibroblasts in pancreatitis,
leading ultimately to fibrosis. The other authors have recently
used the broad inhibitor of kinases, PP2, and concluded that
Src family kinases are the key mediators of inflammation and
acute pancreatitis (Nuche-Berenguer et al., 2016). However,
despite common use of PP2 as a “selective” inhibitor of Src-
family kinases, extensive research has shown that this particular
compound is non-selective and blocks many other kinases with
similar affinities (Brandvold et al., 2012). On the other hand,
the broad kinase inhibitor, PP2, could prevent redundancy
of Src family kinases and other kinases and thus be more
effective in inhibiting acute pancreatitis than the selective Lyn
inhibitor, INNO-406. In any case, we conclude here that the
exact biochemical mechanism for the involvement of Lyn in
pancreatitis-induced fibrosis is still unknown and this is the
legitimate object of additional studies.
Our studies uncover an essential role of the Src family kinase
Lyn in the development of pancreatic fibrosis. Interestingly,
a role for Src family kinases in activated myofibroblasts was
recently reported in pulmonary fibrosis (Hu et al., 2014).
However, this earlier study (Hu et al., 2014) was not designed
to specifically address the individual roles of any specific Src
kinase member in activated myofibroblasts. In the present paper,
we use specific Lyn kinase inhibitors (siRNA or INNO-406)
and discover a role of the Src family kinase Lyn as a positive
regulator of activated myofibroblast migration, proliferation, and
collagen production, which are all characteristics of fibrosis.
We conclude that Lyn is an emerging relevant target in anti-
fibrotic therapeutic strategies, and the inhibition of Lyn kinase
in stellate cells prevents the replacement of parenchyma with
fibrotic tissue in pancreas. Since fibrotic process, which result
from myofibroblast activation, can occur in many tissues within
the body, the role of Lyn might be a general phenomenon
and relevant in other tissues besides pancreas, as it was
previously suggested by other authors (Pontrelli et al., 2006;
Mòdol et al., 2011). Notably, reactive nitrogen species generated
in inflammation can create nitrated biomolecules in various
tissues and the role of tyrosine nitration in the mechanism of
stable Lyn tyrosine kinase activation was previously reported
in other tissues besides pancreas (Mallozzi et al., 2001).
This would explain why cultured stellate cells of chronic
pancreatitis patients sustain their biological behavior at early
passage in vitro, for example, the very high Lyn kinase activity
(Figure 1A). Moreover, Lyn-mediated pathways might also
be potentially relevant to tissue injury or radiation therapy-
induced fibrosis (Leung et al., 2002), which are likely associated
with activation of myofibroblasts. Future studies directed at
the upstream and downstream signaling elements coupled to
Lyn should prove informative, as will investigation of the
transcriptional factors by which Lyn links to collagen-related
gene regulation in activated myofibroblasts in pancreas and other
tissues.
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